Xcout Intel
Arcellx, Inc.
Arcellx, Inc. is a clinical-stage biotechnology company headquartered in Gaithersburg, Maryland, dedicated to developing innovative immunotherapies and cell therapies for cancer patients.
Subscribe to see Arcellx, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Arcellx, Inc. at a glance
Arcellx, Inc. is a biotechnology company headquartered in United States. Its most recent funding round, Seed, raised $25M in January 2024.
Arcellx, Inc. funding rounds
The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $25M | 2 named | |
| SEC Form D filing | $100M | — | |
| SEC Form D filing | $10M | — | |
| Series C | $120M | 12 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Arcellx, Inc. news
Investors
Arcellx, Inc. competitors
A few of Arcellx, Inc.'s closest competitors — see the full list of competitors and alternatives →
ImmuXell Biotechnology is a clinical-stage biopharmaceutical innovation company headquartered in Shanghai, China. Founded in 2021, the company focuses on developing novel immune cell therapies targeted at treating solid tumor cancers.
AbelZeta is a global clinical-stage biopharmaceutical company pioneering T cell-based therapies targeting cancer, inflammation, and immunological issues, with centers in Rockville, Maryland and Shanghai, China.
Alloplex Biotherapeutics, Inc. is a privately owned clinical-stage cellular therapeutics company with headquarters and laboratories located in Woburn, Massachusetts, developing robust platforms for treating cancer.
Imvax, Inc. is a clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, focused on developing personalized, whole-cell immunotherapies for the treatment of various cancers.
OncoC4, Inc. is a privately held, late clinical-stage biopharmaceutical company based in Rockville, Maryland, focused on discovering and developing novel medicines for cancer treatment.
ImmPACT Bio USA, Inc. is a clinical-stage biotechnology company headquartered in West Hills, California. The company focuses on developing advanced cell therapies and immunotherapies to treat cancer and other serious diseases.
Get Arcellx, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Arcellx, Inc. in Xcout Intel
- 6 funding rounds with the investors in each, and who they co-invest with
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access